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Fibrinolytic Responses to
Moderate Intensity Exercise
Comparison of Physically Active and Inactive Men
Linda M. Szymanski, Russell R. Pate
Abstract The purposes of this study were to compare
fibrinolytic responses to moderate intensity exercise in physically active and inactive men and during morning and evening
exercise. Fourteen physically inactive men (mean age,
34.7±4.0 years) and 12 regularly active men (34.8±4.0 years)
performed two exercise sessions, morning and evening, at 50%
of maximal oxygen consumption. Tissue plasminogen activator
(TPA) and plasminogen activator inhibitor-1 (PAI-1) activity
were measured before and after exercise. Data were analyzed
using a three-way ANOVA with repeated measures. TPA
activity increased with exercise in both groups, although the
active group demonstrated greater increases than the inactive
group. Postexercise TPA activity was greater with evening than
morning exercise. The inactive group exhibited greater PAI-1

activity than the active group. PAI-1 activity was higher during
the morning than evening but did not change with exercise for
either group. We conclude that moderate intensity exercise
increases TPA activity in physically active and inactive men,
with greater increases seen in active men, particularly during
evening exercise. Moderate intensity exercise does not appear
to affect PAI-1 activity. The lower PAI-1 activity in active men
may be one mechanism whereby regular physical activity
lowers the risk for coronary artery disease. (Arterioscler
Thromb. 1994;14:1746-1750.)

E

different times of day on the fibrinoh/tic response to
exercise. Rosing et al10 found significantly greater global
fibrinolytic activity after evening exercise compared
with morning exercise. However, only two subjects were
tested, making it difficult for one to draw firm conclusions from their data.
The purposes of the present investigation were twofold. First, we compared fibrinolytic responses to a
moderate intensity exercise session in physically active
and inactive men. Second, we examined fibrinolytic
responses during morning and evening exercise. We
measured TPA and PAI-1 activities to assess fibrinolytic
activity.

nhanced fibrinolytic activity is often listed as a
benefit of regular participation in physical exercise; however, little is known about the fibrinolytic responses to exercise and potential differences
that may exist between physically active and inactive
individuals. Although it is well documented that shortterm physical exercise increases fibrinolytic activity,1-5
most studies describe global fibrinolytic activity and
have not measured the fibrinolytic components tissue
plasminogen activator (TPA) and its inhibitor plasminogen activator inhibitor-1 (PAI-1). In addition, few
studies that examined fibrinolytic responses to exercise
have controlled for the physical activity status of subjects. Studies measuring global fibrinolytic activity5 and
the fibrinoh/tic components6 report that the activity
status of subjects significantly influences the magnitude
of change in fibrinolytic variables in response to maximal exercise. Furthermore, few studies have described
the responses to a typical submaximal exercise session.
Resting fibrinolytic activity is lowest in the morning
and increases throughout the day.7"11 Lower morning
values have been attributed to low TPA activity and
high PAI-1 activity.712 These resting diurnal variations
appear to affect the fibrinolytic response to exercise.
Data from our laboratory13 suggest that evening exercise produces greater increases in TPA activity than
morning exercise. We are aware of only one other study
that has examined the effects of exercise performed at
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Methods
Subjects
Subjects were 26 apparently healthy adult men 28 to 43 years
of age. All subjects were nonsmokers, nondiabetic, nonobese,
and had no evidence of type IV hyperlipoproteinemia. Subjects were not currently taking any medications, including
aspirin. Inactive subjects (n=14) had not participated in
regular physical activity for at least the previous 3 months.
Regularly active subjects (n=12) had participated in regular
physical activity (jogging) for approximately 30 minutes per
session 3 to 5 d/wk for the previous 3 months or more. All
subjects volunteered to take part in the study and gave written
informed consent before participation. The protocol was approved by the university's Institutional Review Board.

Design
All subjects underwent a maximal graded treadmill exercise
test to determine their maximal oxygen consumption
(Vo^max) and then on separate days performed two 30-minute
submaximal exercise sessions on the treadmill. The submaximal sessions were at 50% of their VO2max, one in the morning
and one in the evening. The order of the sessions was
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randomized and counterbalanced. All morning testing was
conducted between 6:30 and 10 AM, and evening testing was
conducted between 4 and 7 PM with at least 2 days separating
sessions. Subjects reported to the morning testing session in a
fasted state (12 hours) and were instructed not to engage in
physical activity at least 24 hours before a testing session, to
refrain from ingesting aspirin and nonsteroidal anti-inflammatory drugs 14 days before a testing session, and to maintain
similar eating patterns throughout the study. Instructions
before an evening session were to refrain from eating at least
3 hours before the testing session and to refrain from ingesting
caffeine after 10 AM.

Blood Collection
Blood was collected before and immediately after exercise
with subjects in the seated position. Preexercise samples were
obtained after 10 minutes of sitting rest. Blood samples were
drawn by venipuncture from an antecubital vein with little or
no stasis into 5-mL vials containing 50 //.L of 15% K3-EDTA.
The first vial was used for hematocrit and hemoglobin determinations. The second vial was used for TPA and PAI-1
determinations. Anticoagulated blood was combined 2:1 with
0.5 mol/L sodium acetate (pH 4.2) within 60 seconds of being
drawn to stabilize TPA activity. Blood was centrifuged at
lOOOg for 10 minutes at room temperature. Plasma was separated and stored at -80°C until analyzed.

Experimental Conditions
Maximal Graded Exercise Test
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acetic acid to the solution. Absorbance was measured at 405
nm. A standard curve made with one-chain melanoma-derived
TPA (American Diagnostica) was developed to determine
TPA activity. Results were multiplied by 1.5 to correct for
acetate buffer dilution and were also corrected for changes in
plasma volume.

PAI-1 Activity
PAI-1 activity (expressed in arbitrary units [AU]) was
measured by chromogenic assay according to the standardized
method of Chandler et al.18 Briefly, plasma was diluted 1:2,
1:5, 1:10, and 1:20 with phosphate-buffered saline (PBS)/
Triton X buffer containing 1 g bovine albumin and 0.6 mmol
sodium azide per liter. Then, 200 fiL of the diluted plasma was
mixed with 200 /AL of 10 IU/mL one-chain TPA reagent
(diluted in PBS/Triton X buffer) and incubated for 15 minutes
at 37°C to allow TPA and PAI-1 to react. The reaction was
stopped and any a2-plasmin inhibitor was destroyed by addition of 200 fiL of 0.5 mol/L sodium acetate buffer (pH 4.2) to
the solution. Residual TPA was measured as described above.
Since plasma dilutions that inhibit less than 8% and more than
50% of the original TPA have produced inaccurate results,18
only dilutions that inhibited between 8% and 50% of the
original TPA were used to determine residual TPA activity.
One AU of PAI-1 activity was defined as the amount of PAI-1
that inhibited one IU of TPA under the specified conditions.
Results were corrected for changes in plasma volume.
Samples from each subject were analyzed at one time to
control for interassay variations. For determination of interassay variation for the fibrinoh/tic variables, blood drawn from a
single individual was stored in aliquots and assayed with each
batch.

A modified Balke treadmill exercise protocol14 designed to
fatigue all subjects within 11 to 15 minutes was used. Heart
rate was monitored via electrocardiography. Oxygen consumption was continuously monitored by an automated system
(Rayfield Equipment) using an Applied Electrochemistry
S-3A O2 analyzer (Ametek), a Beckman LB-2 carbon dioxide
analyzer, and a Parkinson-Cowan gasometer. Vo^max was
defined as the highest oxygen consumption observed during
any full minute of the exercise test. The criteria used for
attaining VO2max included a plateau of oxygen consumption
with an increasing work rate, a respiratory exchange ratio
^ 1.05, and/or a maximal heart rate within 5 beats per minute
of age-predicted maximum.

Height, weight, and skinfold thicknesses were measured on
all subjects. Body fat was determined using four sites (abdomen, ilium, tricep, thigh) according to equations by Jackson
and Pollock.19 To screen for hypercholesterolemia and hyperlipoproteinemia, total cholesterol, high-density lipoprotein
cholesterol, and triglyceride concentrations were measured
before participation (Abbott Vision). Blood was drawn in the
morning with subjects in a fasted state (12 hours).

Submaximal Exercise Sessions

Statistical Analyses

The two submaximal sessions were performed on the treadmill for 30 minutes. Workloads were determined using the
heart rate and oxygen consumption data from the maximal
exercise test. To ensure subjects were exercising at appropriate
intensities, oxygen consumption was monitored for 5 to 10
minutes during each exercise session.

One-way ANOVA was used to compare demographic and
descriptive variables between the groups. TPA and PAI-1
activities were analyzed before and after submaximal exercise
using a 2 (group) x 2 (time of day, morning versus evening) x 2
(time, before versus after) ANOVA with repeated measures.
Least-squares means were computed to make preplanned
comparisons. Statistical significance was reached at a value of
P<.05.

Blood Analyses
Hematocrit and Hemoglobin
Hematocrit was measured in triplicate using the standard
microhematocrit technique. Hemoglobin concentration was
assayed in duplicate using the cyanmethemoglobin method.15
Percent changes in plasma volumes were estimated from the
hematocrit and hemoglobin values.16

TPA Activity
TPA activity (expressed in international units [IU]) was
measured by chromogenic assay under the optimal conditions
as described by Chandler et al.17 Briefly, 5 tiL anticoagulated,
acidified blood was added to 250 fiL plasminogen-chromogenic substrate reagent consisting of 75 mmoI/L Tris-acetic acid
(pH 8.15 at 37°C), 0.1% Triton X-100, 0.50 /unol/L human
Glu-plasminogen (American Diagnostica), 0.65 mmol/L
S-2251 substrate (Kabi Diagnostica), and 80 Mg/mL CNBrcleaved fibrinogen and was incubated at 37°C for 90 minutes.
After incubation, the reaction was stopped by addition of 25%

Other Measures

Results
Descriptive Characteristics
Table 1 summarizes descriptive characteristics of the
subjects. As expected, the regularly active men had a
significantly lower percentage of body fat and attained a
significantly higher Vc^max than the inactive men.
Table 2 summarizes results from the exercise sessions.
The actual oxygen consumption measured during submaximal exercise sessions closely approximated 50% of
maximum for both groups for both sessions.
TPA Activity
Fig 1 presents results for TPA activity (IU per
milliliter) corrected for estimated changes in plasma
volume before and after the submaximal exercise sessions. ANOVA found significant main effects for time of
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Descriptive Characteristics of Subjects
Inactive
(n=14)

Active
(n=12)

Age, y

34.7±4.0

34.8±4.0

Weight, kg

83.5±16.6

79.8±10.3

Body mass index, kg/m2

26.2±4.8

24.5±2.7

Body fat, %

21.3±5.1

16.5±5.8*

Total cholesterol, mmol/L

4.79±0.98

4.14±1.00

HDL cholesterol, mmol/L

1.07±0.28

Variable

4.0abc

=•

3.5-

3

3.0-

""

2.5-

I

2.0-

o

1.5-

1.18±0.25

<

1 0

Triglyceride, mmol/L

1.48±1.07

0.98±1.37

£

0.5-

V02max, mL • kg"1 • min"1

38.6±5.6

51.4±3.9*

0.0
Post

Pre

HDL indicates high-density lipoproteln. Values are mean±SD.
*P<.05 between groups.

day (P<.005) and time (P<.001). Larger increases in
TPA activity were observed after evening exercise than
morning exercise, and postexercise values were greater
than preexercise values. Although the active group had
slightly higher preexercise TPA activity, this difference
was not statistically significant. Exercise produced significant increases in TPA activity in both groups for
both sessions. Postexercise TPA activity in the active
group for the evening session was significantly higher
than all other postexercise values.
PAI-1 Activity
Fig 2 shows results for PAI-1 activity (AU per milliliter) corrected for estimated changes in plasma volume.
ANOVA indicated significant main effects for group
(P<.005) and time of day (P<.05). Higher PAI-1 activity values were observed in the inactive gTOup compared
with the active group, and PAI-1 activity was higher in
the morning than in the evening. Preexercise PAI-1
activity was higher in the morning sessions compared
with evening sessions, but this was significant in the
inactive group only. PAI-1 activity did not change with
exercise in either group for either session (P>.05).
Intra-assay and Interassay Variations
The intra-assay and interassay coefficients of variation for TPA were 4.7% and 5.6%, respectively, and for
PAI-1 activity were 2.5% and 5.7%, respectively.

Discussion
This investigation compared the fibrinoh/tic responses
to moderate intensity physical exercise in habitually
physically active and inactive men and also compared
the responses to exercise performed in the morning and
evening. The major findings were that moderate intenTABLE 2.

"

FIG 1. Une graph shows tissue plasminogen activator (TPA)
activity before and after exercise in physically active and Inactive
men. Exercise was performed at 50% NAynax during the morning and evening. Values are mean±SEM. a Indicates postexercise value different from preexercise (P<.05); b, different AM and
PM values (P<.05); and c, PM value in active group higher than
other values P<.05).

sity exercise increased TPA activity in physically active
and inactive men regardless of whether the exercise was
performed in the morning or evening and greater increases were observed in the active group than the
inactive group. Additionally, postexercise TPA activity
was greater with evening exercise than morning exercise. PAI-1 activity was significantly higher in the inactive group and did not change significantly with exercise
in either group.
There is some disagreement in the literature regarding the effect of activity status or fitness status on
fibrinolytic activity. Cross-sectional studies examining
resting global fibrinolysis in active and inactive individuals report conflicting results. Higher fibrinolytic activity has been reported in active individuals,20 but not all
studies agree with this finding.2-5 Few studies have
measured the fibrinolytic components TPA and PAI-1.
However, greater global fibrinolytic activity5 and greater
increases in TPA activity* have been reported after
exercise in active individuals compared with their inactive counterparts. Exercise training studies21-22 have also
reported beneficial changes in both resting TPA and
PAI-1 activity; however, not all study designs included
control groups, making it difficult to confidently attribute the observed changes solely to the training
program.
The mechanisms responsible for increased fibrinolytic
activity with short- and long-term exercise have not yet
been completely resolved. Recent investigations by
Chandler et al23-24 demonstrate that TPA levels in the

Submaxlmal Exercise Results
Submaxlmal Exercise Sessions
Inactive

Active

5 0 % AM

50% PM

5 0 % AM

50% PM

50% VOjmax, mL • kg"1 • min"1

19.3±3.3

19.6±3.1

25.9±3.0

25.8±2.7

Respiratory exchange ratio

0.89±0.03

0.90±0.02

0.88±0.02

0.91 ±0.03

Caloric expenditure, kcal

233±34

239±36

304±37

303±48

Variable

Values are mean±SD.
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FIG 2. Line graph shows plasminogen activator inhibitor-1
(PAI-1) activity before and after exercise In physically active and
inactive men. Exercise was performed at 50% Vcynax during the
morning and evening. Values are mean±SEM. a indicates
Inactive and active groups are different (P<.05); b, AM and PM
values are different in inactive group (P<.05).

blood are directly proportional to plasma epinephrine
concentrations. deBoer et al25 found increases in TPA
during exercise to be related to reductions in liver blood
flow, suggesting that hepatic clearance of TPA also
plays a role. Additional research is needed to determine
other potential mechanisms that may account for the
increases in TPA with short-term exercise that are not
explained by epinephrine stimulation and hepatic
clearance.
Mechanisms explaining enhanced fibrinolytic activity
as a possible adaptation to regular physical activity are
also not known but may be related to enhanced production or clearance of endothelial proteins. Although few
studies have focused on the mechanisms involved, Stratton et al22 contend that an increase in endothelial
protein production probably does not explain the enhanced fibrinolytic activity observed in physically
trained individuals because they did not observe a
posttraining increase in other endothelial proteins. It
has also been hypothesized that changes in PAI-1
activity may be mediated by the lipid-related changes
that occur with habitual exercise,26 evidenced by the
correlation that has been found between triglycerides
and PAL27 Thus, many questions pertaining to the
mechanisms involved in fibrinolytic changes with exercise are still unanswered; however, the present investigation was not designed to investigate potential
mechanisms.
Impaired fibrinolysis, defined as either low TPA
activity or elevated PAI-1 activity, has been associated
with a variety of thromboembolic diseases.28 Elevated
PAI-1 activity has been documented in survivors of
myocardial infarction26'27 and individuals with coronary
artery disease. 2932 It is possible that the lower PAI-1
activity in physically active men compared with inactive
men observed in the present study and by other investigators26 is an important mechanism mediating the
cardioprotective effect afforded by participation in regular physical activity.33 Since thrombosis appears to be
the immediate cause of most myocardial infarctions,34
impaired fibrinolytic activity may play a crucial role in
its pathology. Participation in physical activity may be a
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relatively simple yet meaningful intervention to beneficially alter the fibrinolytic system.
Although moderate exercise produced significant increases in TPA activity for both groups during both
morning and evening, there was a significant interaction
between time of day of exercise performance and time,
with evening exercise producing greater Increases in
TPA activity than morning exercise. The evening exercise session in the active group elicited the greatest
response. The mechanism responsible for the greater
increases during the evening is not completely understood, although it is most likely due to the underlying
diurnal variations at rest. 711 PAI-1 is hypothesized to be
the major regulator of diurnal variations. Researchers
have found that although TPA activity is lowest in the
morning, TPA antigen is at its highest.7-12 This suggests
that PAI-1 does not affect TPA production and /or
release but rather forms an inactive complex with TPA,
subsequently lowering the amount of active TPA.7-12
This may also be the case during exercise. The higher
TPA activity observed during evening exercise may in
part be explained by the lower PAI-1 activity, resulting
in fewer TPA-PAI-1 complexes and thus more active
TPA.
Whether this enhanced fibrinolytic activity during the
evening is physiologically important is unknown. Unfortunately, it has been suggested, particularly in the lay
literature, that morning exercise may be more likely to
precipitate a cardiac event than evening exercise. This
potentially misleading hypothesis is based on a number
of points, including (1) the knowledge that the incidence of serious cardiac events is higher during the
morning hours,35-36 (2) the finding that exercise enhances coagulation,3-37 and (3) the well-known diurnal
variations in fibrinolytic activity, which is lowest during
the morning. However, no data lend credibility to this
allegation. On the contrary, a recent report38 designed
to examine the safety of morning versus afternoon
exercise in cardiac patients refutes this hypothesis. In
fact, the incidence of severe cardiac events during
submaximal exercise was very low in this high-risk
group, regardless of whether the exercise was performed in the morning or afternoon. No statistically
significant difference in incidence rates was observed,
with 3.0 cardiac events per 100 000 patient-hours in the
morning and 2.4 in the afternoon. Thus, although
exercise enhances coagulation and fibrinolytic activity is
lower in the morning, most available data suggest that
the coagulation and fibrinolytic systems remain in balance in response to stress.37 Furthermore, the general
consensus is that the overall risk of experiencing a
cardiovascular event with exercise at any time of day is
transient and very low,39 and the overall risk of dying is
lower in physically fit individuals compared with their
unfit counterparts.40
In summary, the major finding of this investigation is
that moderate intensity exercise increases TPA activity
in both physically active and inactive men, with greater
increases seen in active men, particularly during evening
exercise. This may represent an increased ability to
activate the fibrinolytic system in response to a stressor,
such as potentially threatening microthrombi that may
form in a coronary artery. These greater increases in
TPA activity and the lower PAI-1 activity observed in
the active men may be important factors mediating the
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cardioprotective effect of regular physical activity. A
well-controlled exercise training study is needed to
provide more information on the role of the fibrinolytic
system as a potential mechanism for the decreased
incidence of coronary artery disease in physically active
individuals and the amount of activity required to
achieve beneficial adaptations.
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